CULTURE IDENTIFICATION AND SENSITIVITY, ANAEROBIC (OTHER SPECIMEN)

The CULTURE IDENTIFICATION AND SENSITIVITY, ANAEROBIC (OTHER SPECIMEN) test isolates and identifies anaerobic bacteria from non‑routine clinical samples (for example deep wound swabs, abscess pus, tissue biopsies or body fluids) and determines antibiotic susceptibility to pinpoint effective treatments. Conducted using specialised anaerobic transport and laboratory techniques, Touch Connect offers professional home collection across Dubai and the UAE with strict handling and rapid transport to preserve organism viability and ensure reliable results. Timely identification and sensitivity profiles support targeted antimicrobial therapy to speed recovery, reduce complications and limit antibiotic resistance—results should be reviewed with your treating physician for appropriate prescription and follow‑up.

• Specimen type: Other specimen (anaerobic)
• Anaerobic culture growth observation
• Organism identification (genus/species)
• Antibiotic susceptibility testing (MIC and zone diameters)
• Detection of beta-lactamase and key resistance markers
• Comprehensive report with targeted antimicrobial recommendations

• Anaerobic organism identification from non-standard specimens such as tissue biopsies, wound swabs, and pus/abscess aspirates
• Antibiotic susceptibility testing with MIC-based results to guide targeted therapy and reduce empirical antibiotic use
• Home sample collection across Dubai and the UAE by trained technicians using validated anaerobic transport media and secure transport
• Testing conducted in accredited laboratories compliant with CLSI and UAE health authority standards, with secure electronic reports
• Clinical interpretation and actionable antibiotic recommendations to support treating physicians and speed patient recovery

• Identifies anaerobic pathogens from non-standard specimens (deep tissue, abscess aspirate, wound or surgical samples)
• Comprehensive culture plus antibiotic susceptibility (C&S) to guide targeted antimicrobial therapy
• Convenient home collection across Dubai & UAE by trained staff using anaerobic transport media and chain-of-custody procedures
• Laboratory-processed with typical reporting in 48–96 hours and microbiologist-reviewed, clinician-ready results
• Supports appropriate antibiotic selection and follow-up care aligned with UAE clinical practice

• At-home specimen collection using anaerobic transport media by trained phlebotomists across Dubai and the UAE
• Species-level identification of anaerobic pathogens from non-sterile and other specimen types using validated laboratory methods
• Comprehensive antibiotic susceptibility testing with MIC values and interpretive guidance to support targeted therapy
• Clinically actionable report delivered to patients and treating physicians with typical turnaround 48–120 hours, processed in UAE-accredited labs